Viemed Healthcare Authorizes New 5% Share Repurchase Program and Issues Strong 2026 Guidance
VMD sits 68% above its 52-week low of $5.93 on elevated volume (3.6× avg).
Summary
Viemed Healthcare announced new 2026 financial guidance and authorized a significant new share repurchase program for up to 5% of outstanding shares, signaling continued growth and management confidence.
Key Events · Financing and Capital Events · VMD
-
New 2026 Financial Guidance Issued
The company provided full-year 2026 guidance, projecting net revenue between $310 million and $320 million, and Adjusted EBITDA between $65 million and $69 million.
-
Significant Share Repurchase Program Authorized
The Board authorized a new share repurchase program for up to 5% of the company's outstanding shares, following a previous authorization mentioned in the 10-K on March 4, 2026.
-
Strong Financial Performance Continues
The guidance builds on strong 2025 results, including $270 million in net revenue and $61 million in Adjusted EBITDA, as previously reported in the 10-K on March 4, 2026.
Analysis · VMD · Industrial Applications And Services
Viemed Healthcare's 8-K filing, accompanying an investor presentation, provides new full-year 2026 financial guidance, projecting continued revenue and Adjusted EBITDA growth. Crucially, the company's board has authorized a new share repurchase program for up to 5% of its outstanding shares. This capital allocation decision, following a previous repurchase authorization noted in the recent 10-K, signals management's confidence in the company's valuation and future prospects, especially as the stock trades near its 52-week high. The guidance and repurchase program reinforce the positive outlook established in the recent strong 2025 financial results.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 30.2% of the 1644 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, VMD was trading at $9.97 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $377.5M. The 52-week trading range was $5.93 to $10.06. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.